Ruddington’s Role In COVID-19 Treatment

A Ruddington based drug development company has announced a new collaboration which aims to speed up the process of getting a drug to reduce Coronavirus symptoms into human clinical trials. Quotient Sciences, which has its head office at Trent House on Mere Way, and employs around 400 staff, has teamed up with Pittsburgh based CytoAgents, Inc – a privately run American biotechnology company which focuses on the development of pharmaceutical products for the treatment of viral infectious diseases. Scientific consensus is building that severe illness caused by COVID-19 and other infectious diseases is triggered…

Read More

Ruddington Makes Awards Shortlist – UPDATE!

A hard working village community group, our newest high street shop and a major drugs development company in Ruddington are all in the running for one of this year’s Celebrating Rushcliffe Awards. Organised by Rushcliffe Borough Council, and co-promoted by West Bridgford Wire, the annual community accolades celebrate volunteers, businesses, clubs, organisations, environmentalists, sports teams and athletes in the district and the best of its health and wellbeing and food and drink sectors in eleven categories. Even though the full shortlist isn’t officially announced yet, we can reveal that no less…

Read More

A Bigger Quotient

A Ruddington-based drug development company has announced it’s taken a major step into the American pharmaceuticals market. Quotient Clinical, which has its head office at Trent House on Mere Way and employs around 250 staff, has acquired SeaView Research for an eight-figure sum. The multi-million pound deal sees Quotient expanding its operations into the USA and will see the firms combine their customer portfolios. All new drugs undergo rigorous testing before they can be prescribed or sold and Quotient Clinical has been operating clinical trials with paid volunteers here in Nottinghamshire for around 20 years. During…

Read More